AC Immune Ltd Working Capital to Net Assets Ratio
AC Immune Ltd working capital to net assets ratio. AC Immune Ltd (ACIU) has a Working Capital to Net Assets ratio of -38.7% as of March 2026. Working capital of $-12.20 Million (current assets of $80.05 Million minus current liabilities of $92.25 Million) is measured against net assets of $31.53 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check ACIU goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of AC Immune Ltd (2013–2025)
Working capital to net assets ratio of AC Immune Ltd from 2013 to 2025. This chart shows how AC Immune Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at -38.7%, reflecting working capital of $-12.20 Million against net assets of $31.53 Million USD. See AC Immune Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
AC Immune Ltd Working Capital to Net Assets Ratio by Year (2013–2025)
AC Immune Ltd working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for AC Immune Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see AC Immune Ltd total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 4.5% | $2.03 Million | $44.93 Million | $96.83 Million | $94.80 Million | ▼ -58.9 pp |
| 2024 | 63.4% | $71.16 Million | $112.27 Million | $171.99 Million | $100.84 Million | ▼ -6.1 pp |
| 2023 | 69.5% | $111.58 Million | $160.64 Million | $125.15 Million | $13.58 Million | ▲ +0.5 pp |
| 2022 | 69.0% | $116.61 Million | $168.99 Million | $128.09 Million | $11.48 Million | ▼ -9.7 pp |
| 2021 | 78.7% | $182.61 Million | $231.98 Million | $202.63 Million | $20.03 Million | ▼ -22.3 pp |
| 2020 | 101.1% | $217.75 Million | $215.48 Million | $231.77 Million | $14.02 Million | ▲ +0.0 pp |
| 2019 | 101.0% | $275.26 Million | $272.44 Million | $292.77 Million | $17.51 Million | ▼ -0.2 pp |
| 2018 | 101.3% | $179.85 Million | $177.62 Million | $192.93 Million | $13.08 Million | ▼ -1.3 pp |
| 2017 | 102.5% | $119.78 Million | $116.84 Million | $129.53 Million | $9.75 Million | ▲ +0.7 pp |
| 2016 | 101.8% | $144.97 Million | $142.38 Million | $154.89 Million | $9.92 Million | ▼ -1.3 pp |
| 2015 | 103.1% | $73.25 Million | $71.04 Million | $79.35 Million | $6.10 Million | ▼ -4.5 pp |
| 2014 | 107.6% | $25.25 Million | $23.47 Million | $29.67 Million | $4.42 Million | ▲ +23.9 pp |
| 2013 | 83.6% | $4.07 Million | $4.86 Million | $11.96 Million | $7.89 Million | — |